CF PHARMTECH (02652) spent 384,100 Hong Kong dollars to repurchase 12,000 shares on January 14th.
Changfeng pharmaceutical (02652) issued an announcement, on January 14, 2026, the company spent 384,100 Hong Kong dollars to repurchase 12,000 shares, with a repurchase price of 31.98-32.22 Hong Kong dollars per share.
CF PHARMTECH (02652) has announced that on January 14, 2026, the company spent HK$384,100 to repurchase 12,000 shares at a repurchase price of HK$31.98-32.22 per share.
Related Articles
US Stock Market Move | ZAI LAB (ZLAB.US) rose more than 5%, and Zoci is expected to become its first globally listed product in the oncology field.
Netflix (NFLX.US) is planning to change the all-cash acquisition plan to acquire Warner Bros. (WBD.US) in order to expedite the shareholder voting process.
CHINA HANKING (03788): Founder and Non-executive Director Xia Zhuo has been appointed as Chairman of the Board.
US Stock Market Move | ZAI LAB (ZLAB.US) rose more than 5%, and Zoci is expected to become its first globally listed product in the oncology field.
Netflix (NFLX.US) is planning to change the all-cash acquisition plan to acquire Warner Bros. (WBD.US) in order to expedite the shareholder voting process.
CHINA HANKING (03788): Founder and Non-executive Director Xia Zhuo has been appointed as Chairman of the Board.
